- Roche (OTCQX:RHHBY), Novartis (NYSE:NVS), and Pfizer (NYSE:PFE) are "thought to be kicking the tires," according to the report, which also cites Gilead (NASDAQ:GILD) as a potential buyer.
- A deal could be worth as much as $72 per share.
- BMY has popped 2% to $53.03.
Bristol-Myers 'in play' - StreetInsider
Recommended For You
About RHHBY Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| RHHBY | - | - |
| Roche Holding AG | ||